Evidence map›Paper›PMID 21379329›Full record

ArticlePLoS genetics2011

Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE.

Ellen M Wijsman, Nathan D Pankratz, Yoonha Choi, Joseph H Rothstein, Kelley M Faber, Rong Cheng, Joseph H Lee, Thomas D Bird, David A Bennett, Ramon Diaz-Arrastia and 7 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 160 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
160citing papers in PubMed, 9 pooled it
15.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

160 citing papers in PubMed, 9 syntheses or guidelines pooled it, 235 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. RBFOX1 association with age at onset of Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  18. Article
  19. Review
  20. Article

100 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 9 institutions in 1 country.

Ellen M WijsmanDivision of Medical Genetics, University of Washington, Seattle, Washington, United States of America.
Nathan D Pankratz
Yoonha Choi
Joseph H Rothstein
Kelley M Faber
Rong Cheng
Joseph H Lee
Thomas D Bird
David A Bennett
Ramon Diaz-Arrastia
Alison M Goate
Martin Farlow
Bernardino Ghetti
Robert A Sweet
Tatiana M Foroud
Richard Mayeux
NIA-LOAD/NCRAD Family Study Group
Indiana University School of MedicineColumbia University · USUniversity of Washington · USRush University Medical Center · USThe University of Texas Southwestern Medical Center · USUniversity of Pittsburgh · USUniversity of Puget Sound · USUniversity of Washington Medical Center · USWashington University in St. Louis · US

Funding

National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)U24AG021886 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI TATIANA M. FOROUD · 2002 to 2026
$119.8M
Smartphone-Based "Burst" Cognitive AssessmentsP01AG003991 · NIA · WASHINGTON UNIVERSITY · PI JOHN MORRIS · 1985 to 2026
$69.5M
THERAPEUTIC EFFECTS OF INTRA-NASAL INSULIN DETEMIRP50AG005136 · NIA · UNIVERSITY OF WASHINGTON · PI GRABOWSKI, THOMAS J. · 1985 to 2019
$57.2M
WASHINGTON UNIVERSITY ALZHEIMERS DISEASE RESEARCH CENTERP50AG005681 · NIA · WASHINGTON UNIVERSITY · PI FAGAN, ANNE · 1985 to 2019
$52.1M
SUPPLEMENT TO RUSH ALZHEIMERS DISEASE CENTER COREP30AG010161 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI LEURGANS, SUE E. · 1991 to 2020
$49.1M
Satellite Diagnostic and Treatment Clinic CoreP50AG008702 · NIA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI DE JAGER, PHILIP L · 1989 to 2019
$46.3M
TREATMENT OF DEPRESSION IN ALZHEIMER'S DISEASEP50AG005133 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KAMBOH, M. ILYAS · 1985 to 2019
$43.0M
THE ROLE OF ADVANCED CAA IN ALZHEIMER'S DEMENTIAP50AG005134 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI HYMAN, BRADLEY T. · 1985 to 2018
$42.1M
VASCULAR RISK AND COGNITIVE STATUS IN A LATINO POPULATIONP50AG005142 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BRASKIE, MEREDITH NICOLE · 1985 to 2019
$41.0M
VESICULAR LOCALIZATION AND FUNCTION OF PRESENILIN 1 FRAGMENTP50AG005138 · NIA · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI GROSSMAN, HILLEL · 1985 to 2019
$37.9M
Research Education ComponentP30AG010133 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI SAYKIN, ANDREW J · 1991 to 2020
$37.3M
UPenn ADCC Biomarker CoreP30AG010124 · NIA · UNIVERSITY OF PENNSYLVANIA · PI DETRE, JOHN A · 1991 to 2020
$35.1M
NHGRI NIH HHS HHSN268200782096CNIA NIH HHS P01 AG002219NIA NIH HHS P01 AG003991NIA NIH HHS P01 AG007232NIA NIH HHS P01AG02219NIA NIH HHS P01AG03991NIA NIH HHS P01AG05138NIA NIH HHS P01AG07232NIA NIH HHS P30 AG008017NIA NIH HHS P30AG008017NIA NIH HHS P30 AG010124NIA NIH HHS P30 AG010133NIA NIH HHS P30AG010133NIA NIH HHS P30 AG010161NIA NIH HHS P30 AG012300NIA NIH HHS P30 AG013846NIA NIH HHS P30AG013846NIA NIH HHS P30 AG013854NIA NIH HHS P30 AG028377NIA NIH HHS P30AG028377NIA NIH HHS P30 AG028383NIA NIH HHS P30AG028383NIA NIH HHS P30AG10124NIA NIH HHS P30AG10161NIA NIH HHS P30AG12300NIA NIH HHS P30AG13854NIA NIH HHS P50 AG005128NIA NIH HHS P50 AG005133NIA NIH HHS P50AG005133NIA NIH HHS P50 AG005134NIA NIH HHS P50 AG005136NIA NIH HHS P50 AG005138NIA NIH HHS P50 AG005142NIA NIH HHS P50 AG005681NIA NIH HHS P50 AG008702NIA NIH HHS P50AG016579NIA NIH HHS P50 AG016582NIA NIH HHS P50AG016582NIA NIH HHS P50AG05128NIA NIH HHS P50AG05134NIA NIH HHS P50AG05136NIA NIH HHS P50AG05142NIA NIH HHS P50AG05681NIA NIH HHS P50AG08702NIA NIH HHS P50AG165574NIA NIH HHS R01 AG015819NIA NIH HHS R01 AG027224NIA NIH HHS R01AG027224NIA NIH HHS R01 AG041797NIA NIH HHS R37 AG015473NIA NIH HHS R37AG015473NIA NIH HHS U24 AG021886NIA NIH HHS U24AG021886NIA NIH HHS U24 AG026395NIA NIH HHS U24AG026395NIA NIH HHS U24 AG056270
6 · The paper itself

Abstract

Late-onset Alzheimer's disease (LOAD) is the most common form of dementia in the elderly. The National Institute of Aging-Late Onset Alzheimer's Disease Family Study and the National Cell Repository for Alzheimer's Disease conducted a joint genome-wide association study (GWAS) of multiplex LOAD families (3,839 affected and unaffected individuals from 992 families plus additional unrelated neurologically evaluated normal subjects) using the 610 IlluminaQuad panel. This cohort represents the largest family-based GWAS of LOAD to date, with analyses limited here to the European-American subjects. SNPs near APOE gave highly significant results (e.g., rs2075650, p = 3.2×10(-81)), but no other genome-wide significant evidence for association was obtained in the full sample. Analyses that stratified on APOE genotypes identified SNPs on chromosome 10p14 in CUGBP2 with genome-wide significant evidence for association within APOE ε4 homozygotes (e.g., rs201119, p = 1.5×10(-8)). Association in this gene was replicated in an independent sample consisting of three cohorts. There was evidence of association for recently-reported LOAD risk loci, including BIN1 (rs7561528, p = 0.009 with, and p = 0.03 without, APOE adjustment) and CLU (rs11136000, p = 0.023 with, and p = 0.008 without, APOE adjustment), with weaker support for CR1. However, our results provide strong evidence that association with PICALM (rs3851179, p = 0.69 with, and p = 0.039 without, APOE adjustment) and EXOC3L2 is affected by correlation with APOE, and thus may represent spurious association. Our results indicate that genetic structure coupled with ascertainment bias resulting from the strong APOE association affect genome-wide results and interpretation of some recently reported associations. We show that a locus such as APOE, with large effects and strong association with disease, can lead to samples that require appropriate adjustment for this locus to avoid both false positive and false negative evidence of association. We suggest that similar adjustments may also be needed for many other large multi-site studies.

Indexed as

Genetic Predisposition to DiseaseGenome-Wide Association StudyAdaptor Proteins, Signal TransducingAgedAlzheimer DiseaseApolipoproteins ECase-Control StudiesCELF ProteinsClusterinFamilyGene FrequencyGenome, HumanHeterozygoteHumansMiddle AgedNerve Tissue ProteinsAdaptor Proteins, Signal TransducingApolipoproteins EBIN1 protein, humanCELF2 protein, humanCELF ProteinsCLU protein, humanClusterinNerve Tissue ProteinsNuclear ProteinsRNA-Binding ProteinsTumor Suppressor Proteins

Identifiers

PMID21379329
PMCPMC3040659
OpenAlexW2159228230

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.